1. In vitro anti-tuberculosis effect of probiotic Lacticaseibacillus rhamnosus PMC203 isolated from vaginal microbiota
   Md Abdur Rahim et al, 2022, Scientific Reports CrossRef
2. A Link Between Chemical Structure and Biological Activity in Triterpenoids
   Cunqin Wang et al, 2022, Recent Patents on Anti-Cancer Drug Discovery CrossRef
3. Mechanisms of cancer cell death induction by paclitaxel: an updated review
   Shuang Zhao et al, 2022, Apoptosis CrossRef
4. Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells
   Yu Zhang et al, 2021, Frontiers in Oncology CrossRef
5. Pristimerin in Oxidative Stress and Use in Cancer
   Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
6. Synergistic effects of epoxyazadiradione (EAD) and paclitaxel against triple‐negative breast cancer cells
   Kunnathully Sudhan Sijisha et al, 2024, Fundamental & Clinical Pharmacology CrossRef
7. Fibronectin type III domain-containing protein 5 promotes autophagy via the AMPK/mTOR signaling pathway in hepatocellular carcinoma cells, contributing to nab-paclitaxel chemoresistance
   Yinji Zhou et al, 2022, Medical Oncology CrossRef
8. Pristimerin in Oxidative Stress and Use in Cancer
   Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
9. Pristimerin suppresses AIM2 inflammasome by modulating AIM2-PYCARD/ASC stability via selective autophagy to alleviate tendinopathy
   Huaji Jiang et al, 2024, Autophagy CrossRef
10. Pristimerin Exerts Pharmacological Effects Through Multiple Signaling Pathways: A Comprehensive Review
    Jian Sun et al, 2024, Drug Design, Development and Therapy CrossRef
11. Antiproliferative Effect of Gallic Acid is Mediated via Mitochondrial‐ or ER‐Stress‐Induced Apoptosis and Canonical Autophagy in HT‐29 Cells
    Jie Shao et al, 2024, Journal of Chemistry CrossRef
12. Pristimerin, a triterpene that inhibits monoacylglycerol lipase activity, prevents the development of paclitaxel-induced allodynia in mice
    Altaf Al-Romaiyan et al, 2022, Frontiers in Pharmacology CrossRef
13. Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review
    Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
14. Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
    Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
15. Pristimerin: Natural Occurrence, Biosynthesis, Pharmacology, and Pharmacokinetics
    Do Thi Lan Huong et al, 2024, Revista Brasileira de Farmacognosia CrossRef
16. Accurate delivery of pristimerin and paclitaxel by folic acid-linked nano-micelles for enhancing chemosensitivity in cancer therapy
    Chao Chen et al, 2022, Nano Convergence CrossRef
17. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
    Bartosz Mateusz Gąsiorkiewicz et al, 2021, Investigational New Drugs CrossRef
18. A Hopeful Natural Product, Pristimerin, Induces Apoptosis, Cell Cycle Arrest, and Autophagy in Esophageal Cancer Cells
    Peng Huang et al, 2019, Analytical Cellular Pathology CrossRef
19. ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS
    Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef